hengrui glp-1 💊 ORAL UPDATE 💊 Kailera/Hengrui's HRS-7535 showed 9.8% weight loss in a 44-week Phase 3 trial in China. 🇨🇳 While effective and free of hepatotoxicity, high rates of nausea (70%) and China's Hengrui/Kailera duo just filed

MTHFR (5,10-methylenetetrahydrofolate reductase) Research has shown that some people may be at risk of methylation insufficiency due to reduced MTHFR enzyme function.1 Two common mutations in the MTHFR gene (C677T and A1298C) may contribute to increased levels of homocysteine, a known risk factor for heart disease, atherosclerosis2 and venous thrombosis.3 Those with a genetic mutation in MTHFR will have varying levels of difficulty creating the active form of folic acid which is the important form the body needs to function properly

Alternative splicing: a pivotal step between eukaryotic transcription and translation

When any large caloric deficit drives rapid weight loss, a portion of what comes off is lean mass muscle, connective tissue, organ mass, and the water they hold alongside the fat

doi: 10.1007/BF03261931CrossRefGoogle ScholarPubMed Rezin, G